Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1969 1
1970 3
1971 4
1972 2
1973 4
1974 5
1975 8
1976 13
1977 11
1978 12
1979 11
1980 11
1981 11
1982 16
1983 19
1984 14
1985 19
1986 21
1987 24
1988 20
1989 27
1990 36
1991 26
1992 41
1993 45
1994 26
1995 40
1996 61
1997 60
1998 62
1999 84
2000 100
2001 82
2002 106
2003 92
2004 84
2005 94
2006 140
2007 139
2008 147
2009 151
2010 164
2011 152
2012 216
2013 220
2014 235
2015 211
2016 218
2017 188
2018 228
2019 237
2020 250
2021 289
2022 258
2023 277
2024 94

Text availability

Article attribute

Article type

Publication date

Search Results

4,462 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Malignant Bladder Neoplasm"
Page 1
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.
Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, Li H, Lu J, Wang H, Zhou Q, Huang J, Chen X, Lin T. Xie R, et al. Cancer Res. 2023 May 15;83(10):1666-1683. doi: 10.1158/0008-5472.CAN-22-2233. Cancer Res. 2023. PMID: 36939377
Clinically, NAT10 overexpression was associated with chemoresistance, recurrence, and worse clinical outcome in patients with bladder cancer. ...Moreover, pharmacological inhibition of NAT10 with Remodelin sensitized bladder cancer organoids and mouse xenogra …
Clinically, NAT10 overexpression was associated with chemoresistance, recurrence, and worse clinical outcome in patients with blad …
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
Powles T, Assaf ZJ, Davarpanah N, Banchereau R, Szabados BE, Yuen KC, Grivas P, Hussain M, Oudard S, Gschwend JE, Albers P, Castellano D, Nishiyama H, Daneshmand S, Sharma S, Zimmermann BG, Sethi H, Aleshin A, Perdicchio M, Zhang J, Shames DS, Degaonkar V, Shen X, Carter C, Bais C, Bellmunt J, Mariathasan S. Powles T, et al. Nature. 2021 Jul;595(7867):432-437. doi: 10.1038/s41586-021-03642-9. Epub 2021 Jun 16. Nature. 2021. PMID: 34135506 Clinical Trial.
Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.
Chen X, Zhang J, Ruan W, Huang M, Wang C, Wang H, Jiang Z, Wang S, Liu Z, Liu C, Tan W, Yang J, Chen J, Chen Z, Li X, Zhang X, Xu P, Chen L, Xie R, Zhou Q, Xu S, Irwin DL, Fan JB, Huang J, Lin T. Chen X, et al. J Clin Invest. 2020 Dec 1;130(12):6278-6289. doi: 10.1172/JCI139597. J Clin Invest. 2020. PMID: 32817589 Free PMC article. Clinical Trial.
BACKGROUNDCurrent methods for the detection and surveillance of bladder cancer (BCa) are often invasive and/or possess suboptimal sensitivity and specificity, especially in early-stage, minimal, and residual tumors.METHODSWe developed an efficient method, termed utMeMA, fo …
BACKGROUNDCurrent methods for the detection and surveillance of bladder cancer (BCa) are often invasive and/or possess suboptimal sen …
Pediatric urothelial bladder neoplasm.
Galiya R, Stanislav K, Jawdat J, Benjamin H, Boris C. Galiya R, et al. J Pediatr Urol. 2022 Dec;18(6):833.e1-833.e4. doi: 10.1016/j.jpurol.2022.06.026. Epub 2022 Jun 30. J Pediatr Urol. 2022. PMID: 35871900
INTRODUCTION: Urothelial bladder neoplasm (UBN) is an uncommon lesion in children and adolescents, without established follow-up protocol defined for this patient group. OBJECTIVES: To report our experience and long-term follow-up data on pediatric patients with uro …
INTRODUCTION: Urothelial bladder neoplasm (UBN) is an uncommon lesion in children and adolescents, without established follow- …
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.
Christensen E, Birkenkamp-Demtröder K, Sethi H, Shchegrova S, Salari R, Nordentoft I, Wu HT, Knudsen M, Lamy P, Lindskrog SV, Taber A, Balcioglu M, Vang S, Assaf Z, Sharma S, Tin AS, Srinivasan R, Hafez D, Reinert T, Navarro S, Olson A, Ram R, Dashner S, Rabinowitz M, Billings P, Sigurjonsson S, Andersen CL, Swenerton R, Aleshin A, Zimmermann B, Agerbæk M, Lin CJ, Jensen JB, Dyrskjøt L. Christensen E, et al. J Clin Oncol. 2019 Jun 20;37(18):1547-1557. doi: 10.1200/JCO.18.02052. Epub 2019 May 6. J Clin Oncol. 2019. PMID: 31059311
PATIENTS AND METHODS: We included 68 patients with localized advanced bladder cancer. Patient-specific somatic mutations, identified by whole-exome sequencing, were used to assess circulating tumor DNA (ctDNA) by ultra-deep sequencing (median, 105,000) of plasma DNA. ...CO …
PATIENTS AND METHODS: We included 68 patients with localized advanced bladder cancer. Patient-specific somatic mutations, identified …
Enhanced Endoscopy in Bladder Cancer.
Pearce S, Daneshmand S. Pearce S, et al. Curr Urol Rep. 2018 Aug 17;19(10):84. doi: 10.1007/s11934-018-0833-9. Curr Urol Rep. 2018. PMID: 30116985 Review.
We will review contemporary endoscopic technologies and techniques used to improve our ability to safely identify and resect malignant lesions in patients with bladder cancer. RECENT FINDINGS: Enhanced endoscopic imaging technology may improve detection rates for …
We will review contemporary endoscopic technologies and techniques used to improve our ability to safely identify and resect malignant …
Young population bladder neoplasms.
Çivi Çetin K, Öner S, Erdoğan B, Simşek G, Sezer M. Çivi Çetin K, et al. Eur Rev Med Pharmacol Sci. 2023 Nov;27(21):10454-10461. doi: 10.26355/eurrev_202311_34320. Eur Rev Med Pharmacol Sci. 2023. PMID: 37975369 Free article.
There is no definitive information about the prognosis and clinical behavior of bladder cancer in young individuals. In our study, we aimed to investigate the prognosis and clinicopathological features of bladder tumors in patients under 40. ...CONCLUSIONS: Patients …
There is no definitive information about the prognosis and clinical behavior of bladder cancer in young individuals. In our study, we …
Diagnosis and management of urothelial carcinoma of the bladder.
Tanaka MF, Sonpavde G. Tanaka MF, et al. Postgrad Med. 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283. Postgrad Med. 2011. PMID: 21566415 Review.
Bladder carcinoma is the fourth most common cancer in men and the ninth most common cancer in women in the United States. ...This epithelium, also known as transitional cell epithelium, lines the urinary tract, which extends from the renal pelvis through the ureters …
Bladder carcinoma is the fourth most common cancer in men and the ninth most common cancer in women in the United States. ...This epi …
Leiomyoma Urinary Bladder, Mimicking Urothelial Cancer.
Bangash M, Faruqui N, Muhammad AU, Uddin Z. Bangash M, et al. J Ayub Med Coll Abbottabad. 2021 Oct-Dec;33(4):685-689. J Ayub Med Coll Abbottabad. 2021. PMID: 35124930 Free article.
Leiomyoma of the urinary bladder is a rare bladder tumour, which is benign in nature. ...Transurethral resection of bladder tumour was performed in both cases and no recurrence was found on initial follow-up. ...
Leiomyoma of the urinary bladder is a rare bladder tumour, which is benign in nature. ...Transurethral resection of …
Therapeutic strategies for upper tract urothelial carcinoma.
Freifeld Y, Krabbe LM, Clinton TN, Woldu SL, Margulis V. Freifeld Y, et al. Expert Rev Anticancer Ther. 2018 Aug;18(8):765-774. doi: 10.1080/14737140.2018.1481395. Epub 2018 Jun 8. Expert Rev Anticancer Ther. 2018. PMID: 29848133 Review.
Many controversies exist regarding the appropriate management of patients with upper tract urothelial carcinoma (UTUC), including staging, surgical management, use of systemic therapy, and prevention of bladder recurrence. Due to the rarity of this condition, high-l …
Many controversies exist regarding the appropriate management of patients with upper tract urothelial carcinoma (UTUC), including staging, s …
4,462 results